clears up the FDA concern . . . the lung macrophages preferentially uptake the liposome (with or without amikacin solution inside) and the lipid builds-up inside these cells. The purpose of macrophages in the lung is to remove foreign materials and assist the immune system in preventing disease. There were no tumors in the rats. There was (probably) lipid pneumonia from no rest period in the 24 month rat study. It is clear from this MB that people posting as bashers or Spumpers do not care about the truth and just want to manipulate the SP for their amusement. Longs took a $6.00 SP hit on August 1, 2011 that can only be regained in stages in the next couple of years. The bottom feeders that went short and bought back in at or near the bottom are the only ones that have gained since. I wonder if INSM management shorted based upon inside information?
Insmed management would be foolish to have shorted publicly as this is a clear conflict of interest;; instead wasn't management allowed to sell a good portion of their cheap shares in the initial runup?The delay is now entering 7 months and the company plan that blew up in less than a year does not bode well for the future.
<<clears up the FDA concern . . . the lung macrophages preferentially uptake the liposome (with or without amikacin solution inside) and the lipid builds-up inside these cells.>>
Rumdum, you have accomplished the impossible!! You have managed to outdo yourself....when it comes to idiocy......The new investor presentation is the same as the last one with the exception of the update on the clinical hold.
Its cool though, that you have figured out how to get to a companies website!! Kudos to you!!